Global Phenylketonuria (PKU) Market Research Report 2011-2023
- HEY1565698
- 82 Pages
- September 2017
- Pharmaceuticals
Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
The global Phenylketonuria (PKU) market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Medications
Supplements
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Biomarin
Vitaflo
Mead Johnson
Nutricia
Cambrooke
Dr. Sch?r
Prominmetabolics
PKU Perspectives
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Household
Hospital
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Medications
1.2.1.2 Supplements
1.2.1.3 Others
1.2.2 by Application
1.2.2.1 Household
1.2.2.2 Hospital
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Medications Market, 2011-2016
4.1.2 Supplements Market, 2011-2016
4.1.3 Others Market, 2011-2016
4.2 Market Forecast
4.2.1 Medications Market Forecast, 2017-2022
4.2.2 Supplements Market Forecast, 2017-2022
4.2.3 Others Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Household Market, 2011-2016
5.1.2 Hospital Market, 2011-2016
5.1.3 Others Market, 2011-2016
5.2 Market Forecast
5.2.1 Household Market Forecast, 2017-2022
5.2.2 Hospital Market Forecast, 2017-2022
5.2.3 Others Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Biomarin
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Vitaflo
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Mead Johnson
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Nutricia
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Cambrooke
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Dr. Sch?r
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Prominmetabolics
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 PKU Perspectives
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Phenylketonuria (PKU)
Table Products Segment of Phenylketonuria (PKU)
Table Medications Overview
Table Supplements Overview
Table Others Overview
Table Global Phenylketonuria (PKU) Market by Type, 2011-2022 (USD Million)
Table Application Segment of Phenylketonuria (PKU)
Table Household Overview
Table Hospital Overview
Table Others Overview
Table Global Phenylketonuria (PKU) Market by Application, 2011-2022 (USD Million)
Table Global Phenylketonuria (PKU) Market by Region, 2011-2022 (USD Million)
Table Cost of Phenylketonuria (PKU)
Table Market Dynamics
Table Policy of Phenylketonuria (PKU)
Table GDP of Major Countries
Table Medications CAGR by Revenue and Volume, 2011-2016
Table Supplements CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
Table Medications CAGR by Revenue and Volume, 2012-2022
Table Supplements CAGR by Revenue and Volume, 2012-2022
Table Others CAGR by Revenue and Volume, 2012-2022
Table Household CAGR by Revenue and Volume, 2011-2016
Table Hospital CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
List Of Figures
Figure Phenylketonuria (PKU) Picture
Figure Industry Chain Structure of Phenylketonuria (PKU)
Figure SWOT of Phenylketonuria (PKU)
Figure Medications Market Size and Growth, 2011-2016 (USD Million)
Figure Medications Market Size and Growth, 2011-2016 (in Volume)
Figure Supplements Market Size and Growth, 2011-2016 (USD Million)
Figure Supplements Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Medications Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Medications Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Supplements Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Supplements Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Household Market Size and Growth, 2011-2016 (USD Million)
Figure Household Market Size and Growth, 2011-2016 (in Volume)
Figure Hospital Market Size and Growth, 2011-2016 (USD Million)
Figure Hospital Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Household Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Household Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Hospital Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Phenylketonuria (PKU) Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
